Skip to main content

Table 2 Response

From: Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone

 

The LAC group

n = 13

The HAC group

n = 7

After four courses

  

 NAD

0 (0%)

0 (0%)

 AD-B

11 (84.62%)

6 (85.71%)

 AD-S

1 (7.69%)

0 (0%)

 AD-W

1 (7.69%)

1 (14.29%)

 

 ORR

11 (84.62%)

6 (85.71%)

 

After eight courses

  

 NAD

0 (0%)

0 (0%)

 AD-B

11 (84.62%)

6 (85.71%)

 AD-S

0 (0%)

0 (0%)

 AD-W

2 (15.38%)

1 (14.29%)

 ORR

11 (84.62%)

6 (85.71%)

  1. LAC, low-dose Ara-c chemotherapy; HAC, high-dose Ara-c chemotherapy; NAD,
  2. nonactive active disease; AD-B, active disease-better; AD-S,active disease -stable;
  3. AD-W, active disease-worse; ORR, overall response rate
Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us